Roth Capital Weighs in on Celsius' Q3 Earnings (NASDAQ:CELH)

Key Points

• Roth Capital analysts have raised their Q3 2025 earnings per share forecast for Celsius Holdings Inc. to $0.22 from $0.18, maintaining a "Buy" rating with a target price of $52.00.
• Celsius reported Q2 earnings of $0.47 per share, exceeding expectations of $0.23, along with a revenue of $739.30 million, marking an 83.9% increase year-over-year.
• Consensus estimates suggest Celsius will achieve $0.89 per share for the current full year, with various analysts issuing optimistic ratings and target price adjustments after a significant price drop.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Research analysts at Roth Capital upped their Q3 2025 earnings per share estimates for Celsius in a note issued to investors on Friday, August 8th. Roth Capital analyst S. Mcgowan now forecasts that the company will post earnings of $0.22 per share for the quarter, up from their previous estimate of $0.18. Roth Capital currently has a "Buy" rating and a $52.00 target price on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q4 2025 earnings at $0.19 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.36 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.24. The company had revenue of $739.30 million during the quarter, compared to analysts' expectations of $632.13 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The firm's quarterly revenue was up 83.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.28 earnings per share.

CELH has been the subject of several other reports. UBS Group lifted their price target on Celsius from $57.00 to $64.00 and gave the company a "buy" rating in a research report on Friday. TD Cowen upgraded Celsius from a "hold" rating to a "buy" rating and boosted their target price for the stock from $37.00 to $55.00 in a research report on Monday, June 16th. Needham & Company LLC restated a "buy" rating and set a $60.00 target price (up from $55.00) on shares of Celsius in a research report on Thursday. Wells Fargo & Company boosted their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Finally, Bank of America boosted their target price on Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research report on Friday. One analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $51.72.

Celsius Price Performance

Shares of NASDAQ CELH opened at $51.95 on Monday. The stock has a market cap of $13.39 billion, a PE ratio of 140.41, a price-to-earnings-growth ratio of 1.80 and a beta of 1.40. Celsius has a fifty-two week low of $21.10 and a fifty-two week high of $53.85. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The stock has a fifty day moving average of $44.51 and a 200-day moving average of $36.21.

Insider Activity

In other news, major shareholder William H. Milmoe sold 100,000 shares of the business's stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $47.50, for a total value of $4,750,000.00. Following the completion of the sale, the insider owned 17,717,770 shares of the company's stock, valued at approximately $841,594,075. The trade was a 0.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO John Fieldly sold 143,167 shares of the business's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $51.18, for a total value of $7,327,287.06. Following the completion of the sale, the chief executive officer directly owned 895,410 shares of the company's stock, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,106,141 shares of company stock valued at $51,985,705. Insiders own 2.20% of the company's stock.

Institutional Investors Weigh In On Celsius

Hedge funds and other institutional investors have recently modified their holdings of the stock. Hantz Financial Services Inc. increased its holdings in Celsius by 1,476.0% during the 2nd quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock valued at $37,000 after purchasing an additional 738 shares during the period. Westside Investment Management Inc. purchased a new position in shares of Celsius during the 1st quarter worth approximately $32,000. Summit Securities Group LLC purchased a new position in shares of Celsius during the 1st quarter worth approximately $34,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Celsius by 255.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after acquiring an additional 750 shares during the period. Finally, Huntington National Bank grew its holdings in shares of Celsius by 939.8% during the 2nd quarter. Huntington National Bank now owns 1,175 shares of the company's stock worth $55,000 after acquiring an additional 1,062 shares during the period. Institutional investors own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.